<SEC-DOCUMENT>0001140361-25-009676.txt : 20250320
<SEC-HEADER>0001140361-25-009676.hdr.sgml : 20250320
<ACCEPTANCE-DATETIME>20250320160144
ACCESSION NUMBER:		0001140361-25-009676
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20250320
DATE AS OF CHANGE:		20250320
EFFECTIVENESS DATE:		20250320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GYRE THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001124105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				562020050
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-285954
		FILM NUMBER:		25756371

	BUSINESS ADDRESS:	
		STREET 1:		12770 HIGH BLUFF DRIVE, SUITE 150
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(619) 949-3681

	MAIL ADDRESS:	
		STREET 1:		12770 HIGH BLUFF DRIVE, SUITE 150
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CATALYST BIOSCIENCES, INC.
		DATE OF NAME CHANGE:	20150820

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGACEPT INC
		DATE OF NAME CHANGE:	20000919
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ef20045895_s8.htm
<DESCRIPTION>S-8
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As filed with the Securities and Exchange Commission on March 20, 2025</div>
    <div style="text-align: right; margin-right: 36pt; color: rgb(0, 0, 0); font-weight: bold;">Registration No. 333-</div>
    <div style="text-align: center; color: #000000; font-size: 14pt; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 12pt; font-weight: bold;">WASHINGTON, D.C.&#160; 20549</div>
    <div>
      <div>&#160;
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center;"></div>
    </div>
    <div>&#160;</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 18pt; font-weight: bold;">FORM S-8</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">REGISTRATION STATEMENT</div>
    <div style="text-align: center; color: #000000; font-style: italic; font-weight: bold;">UNDER</div>
    <div style="text-align: center; color: #000000; font-style: italic; font-weight: bold;">THE SECURITIES ACT OF 1933</div>
    <div>
      <div style="text-align: center; margin-right: 216pt; margin-left: 216pt;"><font style="color: rgb(0, 0, 0);"> </font><br>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 24pt; font-weight: bold;">Gyre Therapeutics, Inc.</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>
    <hr noshade="noshade" align="center" style="height: 2pt; width: 20%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4d9857ef4cae45cb84ee1f5a060e52e5">

        <tr>
          <td rowspan="1" style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-weight: bold;">Delaware</div>
          </td>
          <td colspan="1" rowspan="1" style="width: 2%; vertical-align: top;"><br>
          </td>
          <td rowspan="1" style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-weight: bold;">56-2020050</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(State or Other Jurisdiction of</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Incorporation or Organization)</div>
          </td>
          <td colspan="1" style="width: 2%; vertical-align: top;"><br>
          </td>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(I.R.S. Employer</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Identification No.)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Gyre Therapeutics, Inc.</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">12770 High Bluff Drive, Suite 150</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">San Diego, California 92130</div>
    <div style="text-align: center; color: rgb(0, 0, 0);">(Address, including zip code, of registrant&#8217;s principal executive offices)</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Gyre Therapeutics, Inc. 2023 Omnibus Incentive Plan</div>
    <div style="text-align: center; color: rgb(0, 0, 0);">(Full title of the plan)</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Han Ying, Ph.D.</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Chief Executive Officer</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Gyre Therapeutics, Inc.</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">12770 High Bluff Drive, Suite 150</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">San Diego, California 92130</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(858) 567-7770</div>
    <div style="text-align: center; color: rgb(0, 0, 0);">&#160;(Name, address and telephone number (including area code) of agent for service)</div>
    <div><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0);">Copy to:</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Sean Feller</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Gibson, Dunn &amp; Crutcher LLP</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">2029 Century Park East, Suite 4000</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Los Angeles, CA 90067-3026</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(310) 552-8500</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">
      <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
    <div>
      <div style="text-align: center; margin-right: 216pt; margin-left: 216pt;"><font style="color: rgb(0, 0, 0);"> </font>
        <hr noshade="noshade" align="" style="border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none;"></div>
    </div>
    <div style="color: #000000;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated
      filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>
    <div><font style="color: rgb(0, 0, 0);"> </font><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc3a25eac76814769bcf00b6b43c2b943">

        <tr>
          <td style="width: 25%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Large accelerated filer</div>
          </td>
          <td style="width: 25%; vertical-align: bottom;">&#9744;</td>
          <td style="width: 25%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Accelerated filer</div>
          </td>
          <td style="width: 25%; vertical-align: bottom;">&#9746;</td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: middle;">&#160;</td>
          <td style="width: 25%; vertical-align: middle;"><br>
          </td>
          <td style="width: 25%; vertical-align: middle;"><br>
          </td>
          <td style="width: 25%; vertical-align: middle;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Non-accelerated filer</div>
          </td>
          <td style="width: 25%; vertical-align: bottom;">&#9744;</td>
          <td style="width: 25%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Smaller reporting company</div>
          </td>
          <td style="width: 25%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">&#9746;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 25%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 25%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 25%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 25%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 25%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Emerging growth company</div>
          </td>
          <td style="width: 25%; vertical-align: bottom;">&#9744;</td>
        </tr>
        <tr>
          <td colspan="4" style="vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
              pursuant to Section 7(a)(2)(B) of the Securities Act.&#160; &#9744;</div>
          </td>
        </tr>

    </table>
    <div>
      <div><font style="color: rgb(0, 0, 0);"> </font><br>
      </div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">EXPLANATORY NOTE</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><font style="color: #000000;">This Registration Statement on Form S-8 (this &#8220;Registration Statement&#8221;) is being filed pursuant to General Instruction E to Form S-8 for the purpose of registering an additional 4,315,377
        shares of common stock, par value $0.001 per share, of Gyre Therapeutics, Inc., a Delaware corporation (the "Registrant&#8221;) under the Gyre Therapeutics, Inc. 2023 Omnibus Incentive Plan (the &#8220;Plan&#8221;), pursuant to the provisions of the Plan providing
        for an automatic increase in the number of shares reserved and available for issuance under the Plan on January 1, 2025. In accordance with General Instruction E to Form S-8, this Registration Statement hereby incorporates by reference the contents
        of the Registrant&#8217;s Registration Statements on Form S-8 filed by the Company with respect to the Plan on October 31, 2023 (</font><a href="https://www.sec.gov/Archives/edgar/data/1124105/000114036123050314/ny20009756x9_s8.htm">SEC File No.
        333-275222</a><font style="color: rgb(0, 0, 0);">) and March 28, 2024 (</font><a href="https://www.sec.gov/Archives/edgar/data/1124105/000114036124015774/ef20025363_s8.htm">SEC File No. 333-278291</a><font style="color: rgb(0, 0, 0);">), together
        with all exhibits filed therewith or incorporated therein by reference.</font></div>
    <div>&#160;</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">PART II</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>
    <div>&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z10ab8e3d025c4d79960bd32b9417be56" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

          <tr style="vertical-align: top;">
            <td nowrap="nowrap" style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: left; color: #000000; font-weight: bold;">Item 8. <br>
              </div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="color: #000000; font-weight: bold;">Exhibits.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zee5c60571b314efc89c04ff848c2238c">

        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);"><u>Exhibit No.</u></div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);"><u>Exhibit Description</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">4.1</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="color: rgb(0, 0, 255);"><a href="https://www.sec.gov/Archives/edgar/data/1124105/000095017024126306/gyre-ex3_1.htm">Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the
                Registrant&#8217;s Quarterly Report on Form 10-Q filed on November 13, 2024).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">4.2</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="color: rgb(0, 0, 238);"><a href="https://www.sec.gov/Archives/edgar/data/1124105/000114036122046943/brhc10045912_ex3-1.htm">Certificate of Designation of Preferences, Rights and Limitations of Series X Convertible Preferred Stock
                (incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K filed on December 27, 2022).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">4.3</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="color: rgb(0, 0, 238);"><a href="https://www.sec.gov/Archives/edgar/data/1124105/000114036123050292/ny20009756x10_ex3-2.htm">Amendment to Certificate of Designation of Preferences, Rights and Limitations of Series X Convertible
                Preferred Stock (incorporated by reference to Exhibit 3.2 to the Registrant&#8217;s Current Report on Form 8-K filed on October 30, 2023).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">4.4</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="color: rgb(0, 0, 238);"><a href="https://www.sec.gov/Archives/edgar/data/1124105/000114036123030517/brhc20054638_ex3-1.htm">Certificate of Designation of Preferences, Rights and Limitations of Series Y Preferred Stock (incorporated
                by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K filed on June 20, 2023).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">4.5</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="color: rgb(0, 0, 238);"><a href="https://www.sec.gov/Archives/edgar/data/1124105/000114036123042067/brhc20058284_ex3-1.htm">Certificate of Elimination of Series Y Preferred Stock (incorporated by reference to Exhibit 3.1 to the
                Registrant&#8217;s Current Report on Form 8-K filed on August 31, 2023).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">4.6</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="color: rgb(0, 0, 238);"><a href="https://www.sec.gov/Archives/edgar/data/1124105/000119312517121994/d375894dex31.htm">Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock
                (incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K filed on April 13, 2017).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">4.7</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="color: rgb(0, 0, 238);"><a href="https://www.sec.gov/Archives/edgar/data/1124105/000095017024037242/gyre-ex3_6b.htm">Certificate of Elimination of Series A Preferred Stock (incorporated by reference to Exhibit 3.6(b) to the
                Registrant&#8217;s Annual Report on Form 10-K filed on March 27, 2024).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">4.8</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="color: rgb(0, 0, 238);"><a href="https://www.sec.gov/Archives/edgar/data/1124105/000114036123050292/ny20009756x10_ex3-3.htm">Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.3 to the Registrant&#8217;s
                Current Report on Form 8-K filed on October 30, 2023).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">5.1*</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div><a href="ef20045895_ex5-1.htm">Opinion of Gibson, Dunn &amp; Crutcher LLP.</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">23.1*</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div><a href="ef20045895_ex23-1.htm">Consent of Grant Thornton Zhitong Certified Public Accountants LLP.</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">23.2*</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div><a href="ef20045895_ex5-1.htm">Consent of Gibson, Dunn &amp; Crutcher LLP (included in Exhibit 5.1).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">24.1*</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify;"><a href="#Signature">Power of Attorney (included on the signature page hereto).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">99.1</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; color: rgb(0, 0, 238);"><a href="https://www.sec.gov/Archives/edgar/data/1124105/000114036123050292/ny20009756x10_ex10-2.htm">Gyre Therapeutics, Inc. 2023 Omnibus Incentive Plan (incorporated by reference to
                Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed on October 30, 2023).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">107.1*</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify;"><a href="ef20045895_ex107-1.htm">Filing Fee Table.</a></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; color: #000000;">
      <hr noshade="noshade" align="left" style="height: 2px; width: 10%; color: #000000; background-color: #000000; text-align: left; margin-left: 0px; margin-right: auto; border: none;"></div>
    <div style="color: #000000;">*Filed herewith.</div>
    <div style="color: #000000;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">SIGNA<a name="Signature"></a>TURES</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt; color: #000000;">Pursuant to the requirements of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for
      filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on March 20, 2025.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zeb0004f186184d1cac028889f6fa10ab">

        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;"><br>
          </td>
          <td colspan="2" style="vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Gyre Therapeutics, Inc.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;"><br>
          </td>
          <td style="width: 5%; vertical-align: top;"><br>
          </td>
          <td style="width: 45%; vertical-align: top;"><br>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;"><br>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">By:</div>
          </td>
          <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">/s/ Han Ying, Ph.D.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;"><br>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Name:</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Han Ying, Ph.D.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;"><br>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Title:</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Chief Executive Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">POWER OF ATTORNEY</div>
    <div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; color: #000000;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Han Ying and Ruoyu Chen, or either of them, severally, the individual&#8217;s true and lawful
        attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, to this Registration
        Statement, and any registration statement relating to the offering covered by this Registration Statement and filed pursuant to Rule 462(b) under the Securities Act, and to file the same, with exhibits thereto and other documents in connection
        therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all
        intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each of said attorneys-in-fact and agents or their substitute or substitutes may lawfully do or cause to be done by virtue hereof.</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-indent: 36pt; color: rgb(0, 0, 0);">Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities indicated on March 20, 2025.</div>
    </div>
    <div>&#160;<br>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="color: #000000; font-weight: bold;">Signature</div>
                </div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: bottom; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 51.86%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>
                  <div style="color: #000000; font-weight: bold;">Title</div>
                </div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="2" style="vertical-align: bottom;"><br>
              </td>
              <td rowspan="1" colspan="1" style="width: 1.24%; vertical-align: bottom;"><br>
              </td>
              <td rowspan="1" style="width: 51.86%; vertical-align: bottom;"><br>
              </td>
              <td rowspan="1" colspan="1" style="width: 1.24%; vertical-align: bottom;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Han Ying, Ph.D. </td>
              <td style="width: 19.43%; vertical-align: top; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" rowspan="2" style="width: 51.86%; vertical-align: middle;">
                <div style="color: #000000;">Chief Executive Officer and Director</div>
                <div style="color: #000000;">(<font style="font-style: italic;">Principal Executive Officer</font>)</div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;">
                <div style="color: #000000;">Han Ying, Ph.D.</div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;">&#160;</td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td style="width: 51.86%; vertical-align: middle;">&#160;</td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Ruoyu Chen</td>
              <td style="width: 19.43%; vertical-align: top; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" rowspan="2" style="width: 51.86%; vertical-align: middle;">
                <div style="color: rgb(0, 0, 0);">
                  <div style="color: #000000;">Chief Financial Officer</div>
                  <div style="color: #000000;">(<font style="font-style: italic;">Principal Financial and Accounting Officer</font>)</div>
                </div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;">Ruoyu Chen</td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td style="width: 51.86%; vertical-align: middle;">&#160;</td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: #000000;">/s/ Songjiang Ma&#160; </div>
              </td>
              <td style="width: 19.43%; vertical-align: top; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" rowspan="2" style="width: 51.86%; vertical-align: middle;">
                <div style="color: rgb(0, 0, 0);">
                  <div style="color: rgb(0, 0, 0);">President and Director</div>
                </div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;">
                <div style="color: #000000;">Songjiang Ma</div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td style="width: 51.86%; vertical-align: middle;">&#160;</td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: #000000;">
                  <div style="color: #000000;">/s/ Gordon G. Carmichael, Ph.D.</div>
                </div>
              </td>
              <td style="width: 19.43%; vertical-align: top; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" rowspan="2" style="width: 51.86%; vertical-align: middle;">
                <div style="color: rgb(0, 0, 0);">Director</div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">
                  <div style="color: #000000;">Gordon G. Carmichael, Ph.D.</div>
                </div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td style="width: 51.86%; vertical-align: middle;">&#160;</td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: #000000;">/s/ Thomas Eastling</div>
              </td>
              <td style="width: 19.43%; vertical-align: top; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" rowspan="2" style="width: 51.86%; vertical-align: middle;">
                <div style="color: rgb(0, 0, 0);">Director</div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">
                  <div style="color: #000000;">Thomas Eastling</div>
                </div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td style="width: 51.86%; vertical-align: middle;">&#160;</td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: #000000;">/s/ David M. Epstein, Ph.D.</div>
              </td>
              <td style="width: 19.43%; vertical-align: top; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" rowspan="2" style="width: 51.86%; vertical-align: middle;">
                <div style="color: rgb(0, 0, 0);">Director</div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">
                  <div style="color: #000000;">David M. Epstein, Ph.D.</div>
                </div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td style="width: 51.86%; vertical-align: middle;">&#160;</td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: #000000;">
                  <div style="color: #000000;">/s/ Rodney L. Nussbaum</div>
                </div>
              </td>
              <td style="width: 19.43%; vertical-align: top; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" rowspan="2" style="width: 51.86%; vertical-align: middle;">
                <div style="color: rgb(0, 0, 0);">Director</div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">
                  <div style="color: #000000;">Rodney L. Nussbaum</div>
                </div>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td style="width: 51.86%; vertical-align: middle;">&#160;</td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Renate Parry, Ph.D. </td>
              <td rowspan="1" style="width: 19.43%; vertical-align: top; padding-bottom: 2px;"><br>
              </td>
              <td rowspan="1" colspan="1" style="width: 1.24%; vertical-align: middle; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" rowspan="2" style="width: 51.86%; vertical-align: middle;">Director</td>
              <td rowspan="1" colspan="1" style="width: 1.24%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="2" style="vertical-align: top;">
                <div style="color: #000000;">Renate Parry, Ph.D.</div>
              </td>
              <td rowspan="1" colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td rowspan="1" colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" style="vertical-align: top;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td style="width: 51.86%; vertical-align: middle;">&#160;</td>
              <td colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 27%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Ping Zhang</td>
              <td style="width: 19.43%; vertical-align: top; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" style="width: 1.24%; vertical-align: middle; padding-bottom: 2px;"><br>
              </td>
              <td colspan="1" rowspan="2" style="width: 51.86%; vertical-align: middle;">Director</td>
              <td colspan="1" style="width: 1.24%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="2" style="vertical-align: top;">
                <div style="color: #000000;">Ping Zhang</div>
              </td>
              <td rowspan="1" colspan="1" style="width: 1.24%; vertical-align: middle;"><br>
              </td>
              <td rowspan="1" colspan="1" style="width: 1.24%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
      </div>
      <br>
    </div>
    <br>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ef20045895_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="color: rgb(0, 0, 0);">
        <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 5.1</font><br>
        </div>
        <div>
          <div> <br>
          </div>
        </div>
        <div>
          <div><img width="184" height="21" src="image0.jpg"></div>
        </div>
      </div>
      <div style="color: rgb(0, 0, 0);"> <br>
      </div>
      <div style="color: rgb(0, 0, 0);">&#160;March 20, 2025</div>
      <div>&#160;</div>
      <div style="color: rgb(0, 0, 0);">Gyre Therapeutics, Inc.</div>
      <div style="color: rgb(0, 0, 0);">12770 High Bluff Drive, Suite 150</div>
      <div style="color: rgb(0, 0, 0);">San Diego, California 92130</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z452de3a8e84147c09dca7c2a93301918" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 28.8pt; vertical-align: top; color: rgb(0, 0, 0);">Re:</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">Gyre Therapeutics, Inc.</div>
            </td>
          </tr>

      </table>
      <div style="color: rgb(0, 0, 0);">
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 28.8pt; vertical-align: top; color: rgb(0, 0, 0);"><br>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="color: rgb(0, 0, 0);">
                  <div style="color: rgb(0, 0, 0);">Registration Statement on Form S-8</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div style="color: rgb(0, 0, 0);"> <br>
      </div>
      <div style="color: rgb(0, 0, 0);">Ladies and Gentlemen:</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt;">We have examined the Registration Statement on Form S-8 (the &#8220;Registration Statement&#8221;) of Gyre Therapeutics, Inc., a Delaware corporation (the &#8220;Company&#8221;), to be filed with the
        Securities and Exchange Commission (the &#8220;Commission&#8221;) pursuant to the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), in connection with the offering by the Company of up to an additional 4,315,377&#160;shares of the Company&#8217;s common stock,
        par value $0.001 per share (the &#8220;Common Stock&#8221;), under the Gyre Therapeutics, Inc. 2023 Omnibus Incentive Plan (the &#8220;Plan&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt;">We have examined the originals, or photostatic or certified copies, of such records of the Company and certificates of officers of the Company and of public officials and such
        other documents as we have deemed relevant and necessary as the basis for the opinions set forth below. In our examination, we have assumed the genuineness of all signatures, the legal capacity and competency of all natural persons, the
        authenticity of all documents submitted to us as originals and the conformity to original documents of all documents submitted to us as copies. We have also assumed that there are no agreements or understandings between or among the Company and any
        participants in the Plan that would expand, modify or otherwise affect the terms of the Plan or the respective rights or obligations of the participants thereunder. Finally, we have assumed the accuracy of all other information provided to us by
        the Company during the course of our investigations, on which we have relied in issuing the opinion expressed below.</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt;">Based upon the foregoing examination and in reliance thereon, and subject to the qualifications, assumptions and limitations stated herein and in reliance on the statements of
        fact contained in the documents that we have examined, we are of the opinion that the Common Stock, when issued and sold in accordance with the terms set forth in the Plan, as applicable, and against payment therefor in accordance with the terms of
        the form of agreement documenting the awards under which the Common Stock may be issued, and when the Registration Statement has become effective under the Securities Act, will be validly issued, fully paid and non-assessable.</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt;">We render no opinion herein as to matters involving the laws of any jurisdiction other than the Delaware General Corporation Law (the &#8220;DGCL&#8221;). This opinion is limited to the
        effect of the current state of the DGCL and the facts as they currently exist. We assume no obligation to revise or supplement this opinion in the event of future changes in such laws or the interpretations thereof or such facts. We express no
        opinion regarding any state securities laws or regulations.</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt;">We consent to the filing of this opinion as an exhibit to the Registration Statement, and we further consent to the use of our name in the Registration Statement and the
        prospectus that forms a part thereof. In giving these consents, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the Commission.</div>
      <div style="color: rgb(0, 0, 0);"><font style="color: #000000;"> </font></div>
      <div style="color: rgb(0, 0, 0);"> <br>
      </div>
      <div style="color: rgb(0, 0, 0);">Very truly yours,</div>
      <div> <br>
      </div>
      <div>/s/ Gibson, Dunn &amp; Crutcher LLP</div>
      <br>
      <div style="text-align: justify;">
        <div style="text-align: left;"><a name="z_mps562677140000000000000008653000000000"></a><font style="font-weight: bold;">Gibson, Dunn &amp; Crutcher LLP</font><br>
          2029 Century Park East Suite 4000&#160; |&#160; Los Angeles, CA 90067-3026&#160; |&#160; T: 310.552.8500&#160; |&#160; F: 310.551.8741&#160; |&#160; gibsondunn.com</div>
        <div style="text-align: left; font-size: 8pt;"><font style="font-size: 10pt;"> </font><br>
        </div>
        <div style="text-align: left; font-size: 8pt;"> <br>
        </div>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ef20045895_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-weight: normal;"><font style="font-weight: bold;"> Exhibit 23.1</font><br>
      </div>
      <div style="text-align: justify; font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
      <div><br>
      </div>
      <div style="text-align: justify;">We have issued our reports dated March 17, 2025, with respect to the consolidated financial statements and internal control over financial reporting included in the Annual Report of Gyre Therapeutics, Inc. on Form
        10-K for the years ended December 31, 2024 and 2023, which are incorporated by reference in this Registration Statement. We consent to the incorporation by reference of the aforementioned reports in this Registration Statement.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">/s/ Grant Thornton Zhitong Certified Public Accountants LLP</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Beijing, China</div>
      <div style="text-align: justify;">March 20, 2025</div>
      <div style="text-align: justify;">&#160;</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify;">
        <div style="text-align: right;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">1</font></div>
      </div>
      <div style="text-align: justify;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
  <br>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ef20045895_ex107-1.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 107.1</font><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; margin-right: 12pt; color: rgb(0, 0, 0); font-weight: bold;">Calculation of Filing Fee Tables</div>
      <div><br>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">FORM S-8</div>
      <div style="text-align: center; color: #000000;">(Form Type)</div>
      <div><br>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Gyre Therapeutics, Inc.</div>
      <div style="text-align: center; color: #000000;">(Exact Name of Registrant as Specified in its Charter)</div>
      <div><br>
      </div>
      <div style="text-align: center; color: #000000;"><u>Table 1: Newly Registered Securities</u></div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zec099d47acf945f2911ea252f78aae7d">

          <tr>
            <td colspan="1" style="width: 1%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.54%; vertical-align: bottom; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Security Type</div>
            </td>
            <td style="width: 22.49%; vertical-align: bottom; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Security Class Title</div>
            </td>
            <td style="width: 11.14%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fee </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Calculation Rule</div>
            </td>
            <td style="width: 12.19%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Amount Registered</div>
            </td>
            <td style="width: 8.04%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proposed Maximum</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Offering Price Per Unit</div>
            </td>
            <td style="width: 11.15%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Maximum</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Aggregate</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Offering Price</div>
            </td>
            <td style="width: 17.34%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fee Rate</div>
            </td>
            <td style="width: 9.1%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Amount of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Registration Fee</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 8.54%; vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">Equity (1)</div>
            </td>
            <td style="width: 22.49%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="margin-left: 1.8pt; color: rgb(0, 0, 0);">Common stock, par value $0.001 per share</div>
            </td>
            <td style="width: 11.14%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; text-indent: -12pt; margin-left: 12pt; color: rgb(0, 0, 0);">Rule 457(a)</div>
            </td>
            <td style="width: 12.19%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; text-indent: -12pt; margin-left: 12pt; color: rgb(0, 0, 0);">4,315,377</div>
            </td>
            <td style="width: 8.04%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; text-indent: -12pt; margin-left: 12pt; color: rgb(0, 0, 0);">$9.99</div>
            </td>
            <td style="width: 11.15%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; text-indent: -12pt; margin-left: 12pt; color: rgb(0, 0, 0);">$43,110,616.23</div>
            </td>
            <td style="width: 17.34%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">$153.10 per $1,000,000</div>
            </td>
            <td style="width: 9.1%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; text-indent: -12pt; margin-left: 12pt; color: rgb(0, 0, 0);">$<a name="z_Hlk193208618"></a>6,600.24</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="4" style="vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Total Offering Amounts</div>
            </td>
            <td style="width: 8.04%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 11.15%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; text-indent: -12pt; margin-left: 12pt; color: rgb(0, 0, 0);">$43,110,616.23</div>
            </td>
            <td style="width: 17.34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.1%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; text-indent: -12pt; margin-left: 12pt; color: rgb(0, 0, 0);">$6,600.24</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="4" style="vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Total Fee Offsets</div>
            </td>
            <td style="width: 8.04%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 11.15%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 17.34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.1%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; text-indent: -12pt; margin-left: 12pt; color: rgb(0, 0, 0);">&#8212;</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: middle; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
            <td colspan="4" style="vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); border-bottom: 4px double rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Net Fee Due</div>
            </td>
            <td style="width: 8.04%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
            <td style="width: 11.15%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
            <td style="width: 17.34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
            <td style="width: 9.1%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-bottom: 4px double rgb(0, 0, 0);">
              <div style="text-align: center; text-indent: -12pt; margin-left: 12pt; color: rgb(0, 0, 0);">$6,600.24</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zde429f6f5a6b4bf9bf3db916afcd4cbb">

          <tr>
            <td style="width: 18pt;">&#160;</td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(1)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">The &#8220;Amount Registered&#8221; represents 4,315,377 shares of common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), of Gyre Therapeutics, Inc. reserved for issuance under the Gyre Therapeutics, Inc. 2023
                Omnibus Incentive Plan (the &#8220;Plan&#8221;). Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement on Form S-8 shall also cover such indeterminate number of additional shares of
                Common Stock as may become issuable to prevent dilution in the event of stock splits, stock dividends or similar transactions pursuant to the terms of the Plan. The &#8220;Proposed Maximum Offering Price Per Unit&#8221; and &#8220;Maximum Aggregate Offering
                Price&#8221; are calculated solely for the purpose of determining the registration fee pursuant to Rules 457(c) and (h) under the Securities Act, and based on the average of the high and low sale prices of the Common Stock, as quoted on The
                Nasdaq Capital Market on March 18, 2025.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>&#160;</div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !" D # 2(  A$! Q$!_\0
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M#J?SSD^2>+_BE"6<3SW$X+*ZE62HU\9F&*RS+JCA/EFLOR[+J4E55*\H*O\
M5XTYSA.G+%2JPG;^5+1/VZOVT/#^HP:I8?M5_M SW-L28XM:^+'C7Q+IS$_\
M_&C^(]9U72+L>@NK&8#J #7Z1_LX?\%U/VA_ -_IVD_M!Z)HWQN\(!Q#?ZYI
M]AIO@WXCV<,EQDW5O<:/;V?A+6C96S-'%IUYH.EW.H&*'[3XCMI3/=2_LA\4
M?^",G["GQ!T[4X_#_P /=<^%.OWT8^S^(O 7C'Q*PLKB.-4A>/PYXHU/Q%X6
M^SGRT^TVUMH]FUP#*ZW$%U*UU7\JW[97['?Q+_8M^+,_PW\>E-9T?4K:76/
M7CW3[*:TT/QQX=6X:W^V6T,DMU_9FLZ?*$M_$/AR6\NKO1;F6W<7%]I6HZ/J
MVI]/ W&GT2OI5O%\(_ZA97@.(H8*=>EE>><.95P[Q'4PU*#>)K\/Y]P]BJU6
MI'!N;JU</A\TH8ITT\55P$L/2K3I9YYDWBUX5*CFZX@Q.*RSVZISQ&#S#%YC
MET)SDE2AF&7YC2A"$JZBH1JO#U*<9/V4<3&I.FI_W,? +]H/X4?M-?#G2_BE
M\'O$\'B7POJ+R6ERC1O9ZQH&L6Z1M?:!XCTF;%UI.LV/FQM+;3!H;FVEMM1T
MZXOM+O;*^N?:J_A5_P"":_[9FM?L?_M!Z'J&H:G*GP@^(E]I?A7XMZ/*[&RC
MTB>Y>#3/&4,32I%#JO@J[O)-26YVO+-H<NNZ2@4ZF)H?[J$=)$22-EDCD571
MT8,CHP#*Z,I*LK*058$@@@@XK_-;Z3W@!BO +CJEE>%Q.)S+@_B*A7S+A+-,
M6H?6Y8?#U*=/'93F$J5.E1GF64U*U!5JU"G"EBL+BL%BU3P]3$5,+A_Z0\,^
M/J/'N12Q<Z=/#9M@*D,-FV$I-NE&K.+E1Q6'4I2FL-BXQFZ<9RE.G5I5Z+E4
M5)5:GX:_\%=/V[/VAOV/_&/P6T?X)Z[X?TFP\;^&?%NI:]'K?A?2_$#37>C:
MIH]K9/;R:A&SVRK#?3K(D;;)#L8@%<G\Z/V;/^"OO[:_Q+_:*^ ?PX\5^+?!
M5SX7^('QJ^%G@GQ);VGP^T"RNKC0/%?CG0M"UB&VO(8A-:7$NG7]PD-S$1)!
M(RRQD,@KU+_@X5_Y*+^S1_V)7Q"_]/OAROQO_8N_Y/%_9-_[.7^!'_JTO"M?
MZ$> _@[X59[]%+).*<Y\.^#\TXDK<'<;8NMGF.R#+L3FE3%8+,^):6$Q$\;5
MH2KRK8:GAL/"C4<^:G&C346E!6_ ./>,^*\O\5L9E."X@S7"Y9#-LBHPP-'%
MU88:-+$8/*YUJ:I)\JC5G5J2FMFYR_F9_H0U_,+_ ,%#_P#@J-^US^SI^V'\
M7_@W\,/$_A'3O W@[_A7_P#8=GJG@C1-8OH?^$A^%W@GQ5J7GZC>1M<7'F:Q
MKFH2Q>83Y,+QP)\D2BOZ>J_AU_X+!_\ *1?]HC_NDG_JB_AE7\>_0-X+X2XZ
M\7N(\HXRX;R;BC*\/X;YQF-#+\\R_#9EA*./H\3\'X:EC*=#%4ZE.&)IX?&8
MJC"JHJ<:6(K03Y:DD_UWQVSO-\AX1R[&9+F.+RS%5.(\'AJF(P=:5"K/#SRS
M-ZLJ,IP:;IRJ4:4W'9RIQ?0[W_A]G^WM_P!#GX"_\-KX;_\ C5'_  ^S_;V_
MZ'/P%_X;7PW_ /&J\@_X)G_LF?#G]LS]H/6?A/\ %#6O&V@^'=.^&'B/QK!>
M^ M1T+2]:;5=(U_PEI5M;RW/B'PWXIL6T][?7KQYXDTU+EIH[9H[N)$ECF_>
M?_AP+^QU_P!%*_:7_P#"Q^%O_P YJO[9\4.(/H6>$'%,^#^,_"SABAG4,!@\
MRE#+_#G+L?A_JN.]I[!_6*=&,7-^RGS0M>-E?='XMPQ@_&OB[*XYQDW%&/G@
MI5ZV&4L1GLZ%3VE!Q51>SE=V]Y6=]=?,_'^T_P""W/[>5O<1S3>*/AU?QQDE
MK2[^&^C);S JR@2-8R65T I(<>3<Q'<JABR;D;[!^!G_  < >,K;4[+3OVCO
M@WX>U;0YIS'=^*?A'-?Z-K.G6Y^Y.?"?BG5]7T_6Y5;B58?$WAY1%\\<<DB>
M5-]#^/\ _@WZ^ EYH%VGPM^-7Q?\.^*!$S6%UX__ .$,\9: \ZY*Q7=AX=\*
M>!-1CBEP(VN(=2E>WW&86USM\A_YH/CI\#_B+^SG\4?%7P@^*>C#1O%_A.\6
M"Y6"4W6EZK87$:W.EZ]H5_Y<0U#1-9L9(;[3KHQ03B*4V]]:V6HV]Y96]\#<
M._0G^D;0S;(N$.#.'</FN PCQ&)P&"R;%\%<18;"2FJ,<TP4\ \''&T*&(JT
MX59TJN-HX>K4P]/,*$:>)P\*\Y[F?C9X=3PF/SC.,;6PE>K[*%:KB</G&75*
MJ7.\+756-25"I4A"3A=4)U(QJO#U7*%1P_T#O@]\9/AM\>_A]H7Q0^$WBFP\
M7^"O$43O8:I9":&2&X@;R[S3=3T^ZC@O])U?3YLPW^EZC;6U[:R8\V$*\;/Z
M=7\<'_!$_P#:9U_X3_M16'P4O;^YF^'?Q[AN]&N=+EG8V6D>/-'TN]U7POXC
MM(&++%=ZA'8W7A.^6W$1OX]7TV:]:8:)8+#_ &$Z]K>G^&M#UKQ%JTPM]*T#
M2=1UK4[@E0(-/TJSFOKV8F1D0"*V@D<EW1!M^9E&2/\ ,CZ1?@?B_ [Q-Q'!
MF'Q.(S?)\SPN&SGA3'UH0^NXS*<?B,1A:6&QD:$8TGF."QV%Q.!KNC"E'%>R
MHXV&'PT,7##T_P"F/#OC:EQQPS2SF5*&$Q="K5P6:8>#E[&CC,/"G4G.C*;<
MOJ]:C6I8BFIRFZ2J.C*I4E2E4E\7_ML_M\_!W]B3PG:WWC(S^*_B'XAMIYO!
M7POT.[MX-;UM(7\E]4U6\E2>+PWX9AGS#-K5W;7,D\J36^D:=JMW;W%O%_,/
M\:O^"RO[;7Q5U2Y;PQXVTWX+^&F,R6OAWX<:-IZ70@<@1/?>*M?MM8\23WT4
M8VM<:;>Z+9R.S2IIL)$8C^$OVC/CIXM_:2^-/C_XS^-+F>35?&FNW-[:6,L[
M3PZ!H$)^S>'O#=B2%5;'0='AL]-@V(GG&![J53<7$SO^IG_!+K_@EIHG[6.@
MW?QR^-^J:UIOPAL-<N]!\,^$] E73M6^(6I:48O[7O;O7MTMQH_A;3+ICI,B
M:;;+JVL:@M_':ZKHJZ29-1_TBX1\!/ ?Z+OA?1\0/&;*\LXGXEA1P?\ :N+S
M?+:7$%&GG6/I\U'AOA3(<2JN7U:U":JTJ>8UJ2Q-;V&)S/$8S+\NA[+!?SEF
MW'O'GBAQ14X>X*Q6(RO+%.L\-'!XF>7U)8+#S49YGFF84^7%4Z<^:$GAJ+Y(
MJI2PT:.)Q#YJOYN?\-H_MB?]'8_M+?\ A]OBC_\ -37H7@3_ (*._MR_#NZ6
MZT/]IWXK:HPN5N6@\=^(9/B7:R,!&IB:V^(<?B>-+9UB -O"(HP6DDC5)9'D
M;^OW1?\ @FI^PCH&EV^D67[,?PTN+6VB6))]:L=0\1ZHZK&L6ZXUKQ!J.IZO
M=2E4#-+<7TLC2%I2WF.['Y _:0_X(B_LM_$_0=0O/@E;ZA\!O'ZI)/IL^G:E
MK/B3P)J-V$0):Z[X:UW4-0N["UE$?E)<^%M1TG[#)*][+INK[/L4OS65_3*^
MBKQ+CUD?$?A14RC)L;55!YEG7!'"&:992IRE95LTP. KX_&4J,5[TOJF$S*<
M'M!Q3FO1Q'@WXI990^O99Q>L5CJ,>?ZMA,ZS?!XB;4=88;$5HTJ4YM^ZE7J8
M:$HZRDG[K^7_ -D3_@NY;Z[K6E>"/VNO"ND>&HM0G2SMOB_X#M;^/1+&5]J0
MR>,_!TTVJ7MK:NV[[5KWAN\N(K>1X@WA>WLQ<W]M_1IIFJ:;K>FZ?K.C7]EJ
MND:K96VHZ7JFG7,-[I^HZ?>PI<V=]8WEL\EO=6EU;R1SV]Q!(\4T3I)&[(P)
M_P Z'XQ_"'Q[\!OB7XN^$OQ,T9]"\9^"]4?3-6L]_G6TRM''<V&J:9=!46^T
MC6-/GM=4TF^156[T^[MY]B%S&O\ 1U_P0=_:NUCQ-H_C;]D[QEJMSJ+^"M*D
M^(7PJDO'>9[+PI)J=KIWC#PM%,8@J6>EZWK&DZWI%M)/+<%=<UU(%2PTZ*.#
MX;Z6?T4>!LLX&J>-'@W1H8+*L-0P.9YYD668B6-R+'Y%F<J*H<1\.R=2N\+&
MB\5AZ^*PF'J2RRKEE26-PD,%]3JPQON>$_BMGF*SQ<%\9RG5QLYU\-@<=B:4
M</CJ..PJFZF6YC%1IQJ2FJ52%&M.,<2L3%4*KKRKPE1_HRK\\OVW?^"D7P/_
M &*M/&C:XTWC[XOZEIS7^@?"KP]>16]\L$BM]CU/QAK307EMX0T2ZE"K!-<6
ME_K%_'YD^CZ'J5O;7<UON?\ !1+]L>Q_8P_9]U3QO8+9W_Q+\67,GA#X4Z+>
M(9K6?Q/=6LL\^O:G;J0\NB>%+!)-6OHR8XK^\&EZ&]Q:OK,5S%_"_P"-/&OB
MSXC>+-?\=>.M?U/Q3XO\4ZG<ZQX@\0:Q<M=:CJ>HW3;I9YY6P H 6*"")8[:
MTMHX;6UAAMH8HD_*?HC?1-I>,GM>.^/'B\+X>9?C:F"P6786K4PF-XLS'#.+
MQ5*.+@E5PF28.35#&8O"RABL5B?:X+!8C#5<-B:]'ZKQ;\5Y<&*&1Y&J-;B'
M%456JUZL55H93AJEU3J2I-\M;&UK.>'HU$Z5."C7KPJ4YTJ57],?C-_P66_;
M>^*FHW1\.>.-)^#/AMY+E;7P]\-="L(;I;5Y&^R?;O%7B&'7/$T^H06Q6.>Z
MTO4-$L;F??<QZ3:?N8;?Y D_;4_;&ED>1OVL/VE TCL[!/CE\3HD!8EB$BB\
M3I'&@)PL<:*B+A455  _0O\ X)_?\$@_&'[4WAJP^+_QEU_6?A7\'-6#2>%;
M32+2U/C_ ,?6:EH_[9TD:M;7>F^&_#3R@_V=K6IZ=JMQK8A>;3]&.DW%EK4_
M[IZ1_P $;?\ @GEIME%:WGP2U/Q!/&JJ^IZO\5OBU#>SD* 7ECT'QMHFG!F(
MW,(-/A3<3M55PH_K[BWQX^A]X%9G7X'RS@3+<XQV55)8+-J'!'!?#>9QP.,P
M[<*F%S3.LZQN51S''T).5/$NGC\SKX:M&IAL74I8FE4HQ_(<KX$\8>.L+3SO
M%9_B,'0Q<57PCSK.LRPOMJ51)QK87 X'#XI86C-*,H*5#"QJP<*M*,Z<HS?\
ML7@+_@H_^W-\.;K[5H7[3GQ4U1C.)W@\>:\WQ.M7.(E:+[/\18?%$<4#+$H,
M5N(54M+)%LEEDD;]G_V1O^"[EGKNJZ5X)_:X\*:9X:^W31V=O\7? =K>+H5K
M*Y<1R^,?"$\^H7MC;-B-+C6O#MY>PQ32!Y/#MG8B>[M_7_VBO^"$?P \7Z!?
M:A^SGX@\0?"/QK:V<SZ7HGB'6-2\9> -7ND&^&TU*75VOO%VC-<L/L[:M::Q
MJL-DCB?_ (1^_:/RI/Y;?BW\)_'WP-^(GBCX5_$[0+GPUXU\'Z@=/UC2[@K(
MN7BCN;.^LKF,M!?:7JEC/;:CI>H6SO;WUA<V]S"Y205ZV08#Z)'TO,GS7!9)
MPUEN5\1X3#.MBH8;)L#PAQYE%.;C1HYG&MEBJX7-L)1JSIP?/7SO*Z-:I2HX
MRA"=>E"IS8_$>+GA%B\+7QV9U\;E=6HJ=-U<97SC(L5))U)X1QQ7)B,%5E%2
MDN6G@<14C&<J-2<:=1Q_T7M$US1O$NCZ7XA\.ZKIVNZ#KEA::KHVM:1>6^HZ
M7JNF7\"7-EJ&G7]I)+:WEG=V\D<]O<V\LD,T3K)&[*P-:E?R3?\ !&S]OS6/
MA7\1=$_98^*&N7-[\*OB3JJ:9\-[W4[I7A^'?C_499GL]*MI)V\R'PUX[U"9
M-->PC:2"P\5W6FZA;6]I#JOB*\E_K9K_ "I\>?!3/_ KCS%<)9O5_M#+L116
M9<-Y]3I.E0SK)JM2=.G6=/FFL/CL+5ISPN8X-SDZ&)I^TI2JX.OA,17_ *GX
M%XTR_CG(J6;X*+H5H3>&S' SES5,%C81C*=/FLO:4:D91JX>LDE4I22E&%:%
M6E3_ )R?^"HG_!2+]J7]E?\ :?/PN^$/B/POIGA$_#OPEXD%KK'@W1M<NUU3
M5[C6HKUQ?7L1G\EUL("D)8K&V\K@-@?G;#_P6W_;TBFBED\6_#VY2.6.1[>;
MX;:"L-PB.&:&5K?[/<"*4 I(8)X9@C$Q2QOM=>@_X+H?\GQ?]T=^'_\ Z6>)
MJ_&^O]>/ 'P+\&N(/!/PQSG._##@?-<VS3@W)L7F.98[AS+,1C<;BJV%C*KB
M,3B:F'=6K7J2?-.K*3FY:MW/Y(\0./.,\NXUXFP.!XFSC"X/"YMB:6'PU'&U
M84:-*,ERTZ<$[1A'I%:+;J?Z(G[-7QZ\)?M-?!+P!\:?!CA=,\9:-%<WVFM(
MDESX?\0VC-9>(O#E]L9@+K1=8@N[%GSMN8HH;R'=;W,+M[I7\AW_  1-_;(_
MX4]\8[G]G+QQJ_V?X=_&_4+8>$IKZYAAL?#?Q82);72T1IWC6*+Q]:1P>&I(
MT:66Y\0VWA."WA03WDK?UXU_DO\ 20\&\7X(^*&<\+QA6GP[CF\ZX0QM3FE]
M9R#&U:GL,/.J_P")B\IK0K97C'+EG5JX58ODA1Q5'F_J_P .N,:/&W#&"S7F
M@L?27U/-Z$;+V.84(Q]K)07PTL5%PQ5"UTJ=94V^>G-(K^87_@H?_P %1OVN
M?V=/VP_B_P#!OX8>)_".G>!O!W_"O_[#L]4\$:)K%]#_ ,)#\+O!/BK4O/U&
M\C:XN/,UC7-0EB\PGR87C@3Y(E%?T]5_#K_P6#_Y2+_M$?\ =)/_ %1?PRK]
M?^@;P7PEQUXO<1Y1QEPWDW%&5X?PWSC,:&7YYE^&S+"4<?1XGX/PU+&4Z&*I
MU*<,33P^,Q5&%514XTL16@GRU))_(>.V=YOD/".78S)<QQ>68JIQ'@\-4Q&#
MK2H59X>>69O5E1E.#3=.52C2FX[.5.+Z'[??\$B_V[/VAOVP/&/QIT?XV:[X
M?U:P\$>&?"6I:#'HGA?2_#[0W>LZIK%K>O<2:?&KW*M#8P+&DC;(SO8 ELC]
MS*_EN_X-ZO\ DHO[2_\ V)7P]_\ 3[XCK^I&O@_IA\-</<(>/_%^0\+9+EG#
M^2X/!<+SPN591@Z. P&'GBN&<IQ.(E2PV'A"E"5?$5:M:JXQ3G4J2G*[;9[W
MA#F>89QP!DN89IC,1C\=7J9HJV*Q5256O45+-<;1IJ=23;?)2IPA&^T8I= H
MHHK^8C]+,[6+B6TTC5+N!@L]KIU]<0L5#!98;:62-BK JP#J"58$'H017\8?
M_#[/]O;_ *'/P%_X;7PW_P#&J_LU\0_\@#7/^P/J?_I%/7^:_7^D_P"S[\.>
M N/L/XKRXVX.X<XKEE5;@E9:\_RG!YF\"L;#BQXM85XNE5]BL2\)AG65.WM/
M84N:_)&W\X^/_$N?\/2X4_L/-\?E7UN.>?6?J6(G0]O[!Y1['VO(US>R]M5Y
M+[>TGW9^M?\ P^S_ &]O^AS\!?\ AM?#?_QJC_A]G^WM_P!#GX"_\-KX;_\
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MF:/KFH11>8#Y,SQSI\\2FORS_P"#>W_DE_[2'_8^^!O_ %'M8K[Q_P""P?\
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ME=)&S#,4I253N05_,M_P^S_;V_Z'/P%_X;7PW_\ &J_H'_X++?\ */7XS_\
M88^%?_JU/!U?Q&U_JY]!+PG\,^.?!W.\WXQX#X4XGS2CXA9SE]',,\R3 9EC
M*>!HY!PMB*6$A7Q5&I4CAZ=?%8FK"DI<D:E>K)*\Y7_E;QTXNXGR'B_ 8/)L
M]S/+,+4X>P>)GA\'BJE&E*O/,<UISJRA%I.<J=&E!RW<816R/]+BOY[_ /@K
M%_P40_::_9)_:*\&?#CX,>(/#.D^%]:^"OAWQM?V^M>$=)U^Z?7]2\<_$;0K
MJ:.\OT::.W;3O#>EHMLI\M)(Y90-TSU_0A7\AG_!?K_D\7X:_P#9M'@[_P!6
ME\9:_D7Z%/"G#/&?CE@<DXMR'*N(\GGPWQ#B9Y9G.!H9A@I8C#X>C*A6EA\3
M"I2=2E*3=.;C>+;::/UKQHS?,\DX(KX[*,=B<NQD<RR^G'$X2K*C65.I4FIP
M4XM/EFDE);/J>2_\/L_V]O\ H<_ 7_AM?#?_ ,:K^I3]A_\ :DT/]KW]G;P5
M\6K![*#Q*8/^$<^)&A6DBG_A'?B!HT%NFNV7D[F>WLM16>T\0Z)'*S2_V%K.
MF&5S-YH'\ %?K-_P2'_;&_X9F_:(MO _B_57M?A%\<9],\)^(C</(UEX=\8>
M>T'@KQ=L&4MHEOKR3P_KER?*@CT?6&U._=TT*U\O^_OI2?10X(SOPLS/-?##
M@C(>'.+^$_:9_AZ'#>4X7+JF?Y;AZ4O[6RBM2P=*#Q5?ZHI8W+(\E2M+'82&
M#H<BQU9O\%\+?%C/,+Q3AL%Q1G6,S'*<WY<!*IF&(E66 Q=22^IXJ$ZC_=TY
M56L/B6Y1@J5;V]2_L(G]J5%%%?XF']I'\[W_  54_P""C'[3_P"R?^TGH?PT
M^#GB+PQI?A2_^$_ACQ=<6VL^#]'UZZ.M:IXC\9:9=RI>WT;3K ]KHEB$M\E$
M=9'7F0UH_P#!)W_@HA^TU^UM^T5XS^''QG\0>&=6\+Z+\%?$7C:PM]%\(Z3H
M%TFOZ;XY^'.A6LTEY8(LTENNG>)-41K9CY;R212D;H4KX$_X+S_\GI>%_P#L
M@'@?_P!3+XD5L?\ ! 7_ )/%^)7_ &;1XQ_]6E\&J_UOQ'A/X9Q^@]'C:/ ?
M"BXO_P"(8X;,_P#659)@%G7]H2Q%*,L;_:/L?K/UF46TZWM.=IM7/Y-CQ=Q.
M_&YY'_;N9_V/_K++#?V;]:J?4_JZHN7L?8WY?9W2?+:US]*O^"[_ ,=+OP#^
MS3X-^#>CWRVNI_'+QDPUN)?,\ZX\"_#U;'7=5@C>.1# ;CQ5?^"5=Y-\=S91
M:A9^4XED>'^1FSL[S4;RTT_3[2YO[^_N8+.QL;."6ZO+R\NI5@MK2TMH%>:X
MN;B9TA@@A1Y9I76.-6=@#^\W_!P+XJN[S]H_X*^"'1A8^'O@E_PE5M(95*O=
M^,?'?BO2+U! (%>-HX? M@S2M=3),)41(+8P2277YD?L$^#H_'G[:'[,?AR=
M#);/\9?!.M7D(5'%Q8^%-7@\5WMM('DB'DW-IHLT$[*_FI#)(T*22A(V_;_H
MFY?@/#3Z*>5\3RP]-5<3E'%GB%G4DXI8J=*>/J8:4YP3:<<BRG+,-+FYI0]D
MU96Y%\3XKUZ_$_BO7RF-63A3QF3\.X/?]U[58>-914[*_P!?QF)E?2,KIW:]
MY_VO?L:?LX:%^RI^SK\.O@]I-O:_VKI.CPZIXXU6"%8Y/$/CW68X[WQ3J\\F
MZ229/[0=M.TL32S/::'I^EZ<DAALX@/J*BL;Q'XBT/PAX>U[Q9XGU2ST/PUX
M7T;5/$7B'6]1F%OI^CZ'HEC/J6K:I?3M\L%GI]A;7%W=3-\L<$+N>%K_  \S
MK.,YXNXAS//,TK5\SSWB/-L5F.-K*,JN(QN99GBIUJOLZ<%*4I5:]9QI4::=
MDX4J<;*,3^W,'A<)E6 PV"PL*>%P.7X6EAZ%--1IT,-AJ2IP3D[)1A3@N:4G
MT<I/=FS7YT_\%-?V-M7_ &SOV?[/P?X(3P_!\4O"'C'1?$O@;4_$=[-I>G0P
M74PT?Q9IU[J=K8ZE<P6%WH-Y+J4D$5G/]JU+0])79YD<9'I7_#Q#]AW_ *.C
M^#O_ (5ME1_P\0_8=_Z.C^#O_A6V5?HW!?#WC/P#Q7D/&7#? ?&^&SOAW,:&
M99?4J<'\0U*$JM)VG0Q-*."INMA,71G4PN+HJ</;8:M5I<T5.Y\_G&.X0S[*
M\?D^8YUDU7!9CAJF%Q$8YK@(S4*BTG3DZTN2K2DHU:-2S<*L(32O$_"7P+_P
M;X_&#4;>*3XD_M"?#GPA<."9;?P9X4\2?$%807;8OGZS=_#<22>7L,H6,1I*
M7CCEFC19Y/Z;OAEX0N_A]\.? ?@.^\17WBZ[\%>#_#?A.?Q3J=O%:ZEXB?P]
MI%II/]M:C!#)+#'?ZD+07=X(Y'0W,LK*<&OFO_AXA^P[_P!'1_!W_P *VRKZ
M9^'WQ$\#_%?PAI'C_P"&_BG1_&G@O7_M_P#8WB;0+M+_ $C4O[+U2]T74?LE
MU'\DOV/5M.OM/GQ]RYM9HSRAKZKQP\3?'[Q)P>55O%[+\XP>399F%=Y+#&<$
M4^&L!A,?F%"];#X?'O*<)B\34KX;!\ZPV)S#%.5/"RK1A>E.HO)X)X8X#X:J
M8JGPC6PE3%XJA2^O.CG53,J]>CAIM0JU:#Q=:E34*E=IU*-"DE*MR-VE&)_-
M#_P<*_\ )1?V:/\ L2OB%_Z??#E?C?\ L7?\GB_LF_\ 9R_P(_\ 5I>%:_9#
M_@X5_P"2B_LT?]B5\0O_ $^^'*_&_P#8N_Y/%_9-_P"SE_@1_P"K2\*U_JQ]
M''_E#/(/^R&X_P#_ %;\5G\J^)/_ ">;'?\ 8ZX<_P#4'*#_ $(:_AU_X+!_
M\I%_VB/^Z2?^J+^&5?W%5_#K_P %@_\ E(O^T1_W23_U1?PRK^&_V<7_ ">_
MBG_LU6>?^M=P,?MWTC?^2(RO_LJL#_ZJ,\/?_P#@@Q_R>EXH_P"R >./_4R^
M&]?V%U_ ]^P9^V%_PQ'\:=4^+_\ PKO_ (6;_:7@#7/ O_"/?\);_P (7Y/]
MLZSX;U?^U/[6_P"$8\6>9]F_X1[[/]A_LR/SOM?F_:XOL_E3_L+_ ,1$?_5G
M_P#YL!_^)*OT_P"F!]&OQJ\4O&*MQ5P)P7_;N0SX:R/+XX__ %CX3RR^+P:Q
M?UFE]5SG/<OQJ]G[6'[QX=4I\W[N<K.WS/A#XD\%<+\'4\JSW.OJ./CF..KN
MA_9V;8FU*M*FZ<_:X/ 8BC[RB_=53F5O>2T/Z7*_D$_X+W7?AZ?]L+P-!IFY
MM<L?@)X5M_$SQR0&V6>3QK\0;O2K>2!;=+A-3CTRYBGNIYKJ>.?3KK1HH(;8
MVLS7'MWCC_@X3\>ZGH-W:?#O]FCPOX/\131/'::WXK^)>I>/-.LW=2JS_P!A
M:;X*\!2W$D1.^-9-96$NJ^;%+'NC;\1+H_'C]KGXQZWK,6E^-?C/\8?B!J4F
MLZLNAZ/>Z[K5ZP-K8K<&RTNV>+2M T>V^P:= 1%9:'X?TF"RM$-CIUK"D?J?
M1#^C!XD^$O'F.\3/%&CEO!N5Y-D&:8&A@JV>Y1CZV+J9@J,*N+QN)RG'XW*\
M'E>#PU.M6J3Q..59XGZLUAU3A.M#G\7/$[AKBW(*/#/"T\3G6,QV/PM656G@
M,;0C1CAY2E&G1IXO#4<37Q5:HX4X1HT7'V;JWJ<W+3G[A_P38\/:GXF_;M_9
MATW29;F&ZMOB=IOB&5[00^:VF>$K*_\ %>M1/Y]K>)]FN-'T6_@O=L23"SDG
M-M=6-QY5[;_VX?M(:#JWBK]G?X]>&- N[FPUWQ'\%_BEH.BWUD9%O++5M8\#
MZ[I^G7=H8I[:47-M>7$,T!CN;>02HA2>)L2+^8W_  2G_P"":FH_LG:???&?
MXSQV<GQU\7Z+_9%CX<M;BUU&S^&'AF[DAN;[3&U*TDGLM1\6:Q)#;)K=[IT]
MQIVG6ELNE:7>WD5SJ-W=_M RJZLCJ&1@596 965AAE93D$$$@@C!'!K^<?IB
M^-?#WB#XV9)FO!6(P^;Y-X?8'+\LP^;TN2K@<ZS7!YOB<WQM?!57"V)RNG4J
MT,#0K6J8?%3PV)Q>%E6P>)HU*GZ/X.\&9AP[P5BL)G=.IAL7G^)Q&,JX.3E"
MM@L+7PE'"4:59*7[K%2ITI5ZB7)5I>UIT:JC6HRC'_-(K^QK_@AW\9?!/C#]
MD'3_ (1Z?JMI'X\^$?B?Q?'XA\.RW,(U231/%GB6_P#%6C>);:RW^>^C7$FM
MW&BFZ"%(]3TJYAE*>;;>;_/_ /\ !2;]B#Q5^Q_\<->GT_1+A_@=\0-<U+6O
MA5XEM()&TNQM;Z674)O &HS*GE6.N^%0\ME:VTLF[5]!MK/6K;+27]IIWPU\
M/OB1X^^$_BK3O&_PT\8^(_ OBW27W6'B#POJUYH^I1(S(TUK)/9RQ&YL+H1K
M'?:==":POX-UM>VUQ;N\3?Z:^*_ W#GTMO _+*?"_$E'"8;-*^6<7<,9OR?6
ML-A\UPF%QF%EE^<8:C-5:;ITLPS#+<QH1E]9R[')U)4:U3"RPU7^9>%,\S'P
MCXXQ;S7+9UIX>EBLHS+"I^RJU,)5K4*T<5@JE1<DE.>&P^)P\Y+V>(P[Y5."
MJJK#_2#HK^.+X7?\%S_VR_!$>GV/C:U^&?Q=T^V58KRZ\3>&)_#WB6[A0,$,
M6K>"]1T+2(;H?NU>YNO#.H^;&C&6)KF1KD?H1\,?^#@GX3ZJ8K;XP? 7QWX+
ME:YB@.H^ O$6B>/[ 02! ]_=6FM0> KZS2&1G,MI:'6IOL\?FPR7$\@M%_RQ
MXK^@Y](?ACVU3#<+9?Q9A*/,Y8OA;/,!BW**DTG2R[,IY5G%9R24E"CEU2:3
M7,DT[?U+E7C=X>9GR1GFU;*ZT[6HYI@L10MHF^?$4(XG!0LVXWEB4FXNUU9O
M[3_;:_X)A?#W]M;XQ?"OXF>)?%]_X&L_">@ZOX<^(,'AG2;63Q/X\T=+N"_\
M(V-EK=[+)IV@R:)=W7B#[5J=YH>O7%S8W\%A#;P>1!<VOV)\ /V7O@3^S!X9
M/A;X)_#S1?!UK<)&-6U6))=0\3>()8N5G\0>)M1DNM:U9E<L\,-U>-9V>XQV
M%K:P!8EP_P!GW]L;]FS]J*UEE^"?Q4\/^+-3M;9KO4/"LWVO0?&>FVT<OD2W
M-YX2UZWTW7EL8YRL1U."QGTMWDB\F]D6:%I/IJOQGC#C7Q>PN0Y7X3\:9IQ7
ME.1\(T983"<%9M1Q630PD)XROCZ?]I9=4HX3$8^I1K8BI]0K9K'%3P>%5+#8
M&='"TJ=./V>49-PI4QV*XJR;"Y7BL;G$HU:V=82=+&.ORT:6'_V?$QG5IT83
MIT8>VAA73A6J\U6M&=:<YO\ C/\ ^"W'QOOOB9^V/??#J"ZN&\,_ GPOHWA*
MPLV\G[&WB;Q)867B_P 6:M:[,S>;<)J6@Z!>>>RC?X6C\J)4_?7'QU^P5^SJ
MG[4G[57PK^$VHPRR>$[K5IO$OCUXRR;/!/A2VDUO7+5I4DCE@;75M;?PU;7,
M):2VO=;M9PNV-B.,_;$\0W7BO]K+]I?7[NY%X^H?'?XK-!,O^K^P6_C?6[33
M(8> ?(MM-M[6VMRV7,,,?F,S[F/ZU?\ !OSX1L=0^/OQP\;S_-?>%_A-IWAZ
MQ1@"J)XP\6Z?>WERH*G;-&O@^&W20,K"&[N$PRRMC_:7/<7+P,^A].MD#6"Q
M_#'A9EF%P6)H0<94N(\]PN#P53-H125J\L_SBIFLG)6]O)RJ)KF3_C# TEQS
MXQJ&/3KX?,>*<75JTJK^/+<MG6KPPD_B3@LOP,,*TGK!<L91TDOZL=-TZPT?
M3K#2-)LK73=+TNRM=.TW3K&".VLK#3[&".VL[*TMH52*WM;6WBC@MX(D6.**
M-(T554 7:**_P'E.4Y2G.4ISG)RG.3<I2E)WE*4G=RE)MMMMMMW>I_>J2222
M225DDK));));)!7X$?\ !>#]FC2?%?P9\,?M.Z)IUK!XN^%FL:5X1\9ZA'&L
M4VJ_#SQ9J!T_2?MDR0/+=S>'?&U_ID.DQ2RPPP6OBK77,C2?9X7_ 'WKY&_;
MY\/6OB?]B?\ :HTV[1)(K;X%?$CQ"BR8VBZ\(^&K_P 5V+C,4HWQWNBV\D7R
M@^8B8EA.)H_U_P  .,\PX"\9?#OB++ZU2DJ?%.4Y=F-.$W%8K)LXQ=+*\WPE
M1+W9JM@,77]FIQG&GB(T:RBYTH-?)<>9-A\^X/XARW$QBU/*\77H3E%2]CB\
M)2EBL)6C?6]/$4J;?*XN4.:',E)G\!%I=W5A=6U]8W-Q9WMG<0W=G>6DTEO=
M6EU;R+-;W-M<0LDL%Q!*B2PS1.LD4BJZ,K*"/]";]DCXS+^T)^S3\%?C$TUO
M/J'C;P'H]WXA:T='MH_%VFH^A^,[6(QX55LO%FEZS9^40KPF Q2(DB,H_P ]
M&O[1_P#@B1KD^K?L&>%+"4@Q^&?B'\2-#ML.'Q!<:XOB1@5"*8C]I\0W!V,7
M)!$N\+(J)_IS^T;X9PF/\*N$>*_9Q_M+AWC.GEM*M9<RRSB'*\?+'4K[OGQN
M493-+5)4YNVK9_,OT<LRK4>*,YRI2?U;'Y*\9.'_ %$Y?C,/3HR2Z?N<=BD^
M_NWO9'XD?\%T/^3XO^Z._#__ -+/$U>,_P#!/G]EVU_:V\+?M:_#6VM;>3QQ
MI?P=TCQI\+[R41J]IX\\.^*8)M-LUN)(Y/LUOXDLYM0\*W\P4^39:W-<A3+;
MQ%?9O^"Z'_)\7_='?A__ .EGB:O<O^#?7_DNWQY_[)+I'_J8Z?7UD.)<VX-^
M@MPSQ7D.(>%SCA[@#@3-\NKZN,<3@<]R*O"%6*:]I0J\CHXBC)\E>A.I1FG"
M<D_.6783-_'C,LKQU-5L'F&<Y]A,33?VJ5?*<?3GRNSY9Q4N:$UK":C.-FDS
M\#E;5O#^K*RG4=$US1-1#*RFYTW5M(U;3;G(92/)O+#4;"\AR"/*N;6YBR/+
MECX_NR_X)R?M=V7[87[-WASQCJ-W;'XF^#_)\%?%G3(LQR1^*M-M8C!XAC@:
M.';IWC+3#;Z_;/;I)8VU]<:KH<%Q-<:)=[/P%_X+8_L;?\*>^,-O^T?X&T@6
M_P .OC;J,_\ PET-E;P0V7AOXLB*2[U.1HH%C,<'CVTAN/$JS,DTD_B*V\53
M7,\?VFQB?Y-_X)B_M@R?LB?M)Z+JGB#4);;X2_$K[%X&^*<!<_9+#3KJ[_XD
M7C22(R)'YO@K5;@WUS<[)[E/#5YXFL[*&2YU!%/!XV\*Y)]+KZ..3>(7!>&C
M5XKR; 5^(L@PE-QK8ZECJ%-4>+."J[C'GG6K2PLX86*A3>*S'+\IKTY0P>*E
M*IIP3FF-\(_$;&<.9U4<<IQU>G@,;6DG&A*C4;GE&=4[^ZH155*N[M4:%?%P
MFG6H*,?[H:_AU_X+!_\ *1?]HC_NDG_JB_AE7]P\<D<T<<L3I+%*BR12QL'C
MDC=0R21NI*NCJ0RLI*LI!!(-?P\?\%@_^4B_[1'_ '23_P!47\,J_D?]G'=>
M.'%2:LUX59XFGT_XR[@8_5_I&?\ )$95_P!E5@?_ %49X??/_!O5_P E%_:7
M_P"Q*^'O_I]\1U_4C7\MW_!O5_R47]I?_L2OA[_Z??$=?U(U^<_3F_Y25XX_
M[ .$/_62R4^E\#_^3:9!_P!?<X_]768!1117\C'ZR8_B'_D :Y_V!]3_ /2*
M>O\ -?K_ $H/$/\ R -<_P"P/J?_ *13U_FOU_JW^S-_W;QG_P"O_A__ .F^
M-#^5?I,?'P7_ (>(?SR,_KS_ ." O_)G7Q*_[.7\8_\ JK?@U7[BU^'7_! 7
M_DSKXE?]G+^,?_56_!JOW%K^)/I4?\I#>+'_ &55?_U%PI^U^%G_ ";WA/\
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M3-)<3_VMI]I+I>K74RH\OB'1M4N61(;RU,GZH5_ =^PC^U9K'['_ .T7X/\
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M_P#U>GQ-K^'6O[BO^"/G_*.C]G?_ +JW_P"KT^)M?LW[1W_DR'"W_9U<C_\
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MK#2;*ZOIACRK0YVCX?Z=_@?DG"?''!7$/A_D"PM7Q&CG&#QO#>0X&4J=7/\
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M4VO=G4HT<79IIN,)K9M'\V/_  70_P"3XO\ NCOP_P#_ $L\35[E_P &^O\
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M].$RND>J^']7@LM8TV8C]W>64).5W*?\_;XV?"+Q?\!/BQX]^#OCNU%KXI\
M>(;O0M1\L-]FO8HPESIFLV!?#OIFO:3<6&MZ5(ZK)+IVH6LCHCLR+]G]$3Q%
MR;Q\\%\_\#N/Y+,,SX=R.61U85IQ>*S3@K$Q6&RC,:$YJ36/X;Q'L,O6)C!R
MPDJ&18R4YXK$2D>/XN</8W@+C/+N.\@7L,-F&/6,O!-4L-G4+U<7AZBC;_9\
MUH^UK.FY?O>;'TN6-*,4_P"QG_@L9=6U]_P3K^+U[93PW=G>:C\);JTNK>19
MK>YMKCXH>#)8+B"6,LDL,T3I)%(C%'1E9200:_B4K]O=%_:]F^-?_!(3XZ?
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MMJ52MA*4I<M+$Z_JU_P7G_Y/2\+_ /9 / __ *F7Q(K8_P"" O\ R>+\2O\
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MPVES+'&R02LO]57_  VE^QU_T=C^S1_X?;X6_P#S55_ W_PJOXH?]$W\>_\
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MQ[H=Y\//#%K%<%\W']L>,(=(AU);=$,MS;:&FJZA%&T)^Q,UQ;K+P^%?T9/
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MXJFGR2K1ARTL+0;2D\-A(RG&G*24JE2I6K.,%55.'\:__!=#_D^+_NCOP_\
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M17\E'ZL8_B'_ ) &N?\ 8'U/_P!(IZ_S7Z_TH?$ )T'6P 23I&I   DDFRF
M  ZDGH*_SF_^%5_%#_HF_CW_ ,(_Q#_\KJ_U2_9JXS"83#>,GUK%8;#>TK\
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BOESM"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
